The World of Thalassemics

   What is Thalassemia       Thalassemia and Malaria       Thalassemics       Deferiprone(L1)       Contact       Society       Home   

What is Thalassemia

Thalassemia comes from the Greek word "thalassemia" which means "anemia by-the-sea." The name thalassemia was coined at the University of Rochester in upstate New York by the Nobel Prize-winning pathologist George Whipple and the professor of pediatrics William Bradford from the Greek thalassa for sea and -emia meaning the blood.

Thalassemia was first described by Cooley and Lee in 1925. Most of their patients were of Mediterranean ancestry and a majority of them suffered anemia. Hence this group of anemias are also known as Cooley's Anemia or Mediterranean Anemia.

The thalassemias are a group of genetic blood disorders that affect a person’s ability to produce hemoglobin. Hemoglobin is the protein in our red blood cells that carries oxygen and nutrients to all parts of the body.

 

Causes of Thalassemia

Thalassemia is an inherited disease it is passed on from parents to their child through their genes. It is an autosomal recessive trait and is not linked by sex chromosomes.
 

People at risk

People who have ancestry from Southeast Asia, southern China, the Middle East, the Mediterranean (Greece, Italy, Turkey), South Asia, parts of North Africa, and parts of the Pacific Islands are at an increased risk for thalassemia.
 

Symptoms of Thalassemia

Severe anemia
Jaundice
Enlarged spleen
Fatigue
Reduced appetite
Growth problems
Increased susceptibility to infection
 

Diagnose of Thalassemia

Blood count
Blood film
Saturated iron binding capacity of serum ferritin levels
Hemoglobin electrophoresis is an important test to diagnose thalassemia.
 

Treatment of Thalassemia

Long term Vitamins like folic acid supplements
Regular blood transfusions may be required.
Splenectomy - spleen may need to be removed.
Bone marrow transplantation - In advaced disease this can be a permanent cure.
A recent development in transplantation involves using blood from the umbilical cord from a newborn baby. Since the baby's cells are immature, there is less chance that the recipient will reject the transplant.
 

Complications from Thalassemia

Complications might occur due to iron overloading by repeated transfusions and hence should be periodically assessed. Intensive research is being carried out on prenatal diagnosis and gene therapy.
 
Write to us

© 2004-2005 Thalassemia Friends.
thalassemics@yahoo.com